Physical Therapists in Valatie, NY Accepting Medicare

10 Physical Therapists found. Showing 1 - 10

Megan Amyot, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2827 Route 9, Valatie, NY 12184 Phone: 518-758-7616    Fax: 518-758-7557

Erica Jean Yap, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3230 Church St, Valatie, NY 12184 Phone: 518-758-6222

Carolyn Becker Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2827 Route 9, Grand Union Plaza, Valatie, NY 12184 Phone: 518-758-7616

Lynshay Anne Lagrimas Macias, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3230 Church St, Valatie, NY 12184 Phone: 518-758-6222

Nicole L Fredericks, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2880 Us Highway 9, Suite 1, Valatie, NY 12184 Phone: 518-758-6070    Fax: 518-758-6379

Lydia A Repnoy, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2827 Route 9, Valatie, NY 12184 Phone: 518-758-7616    Fax: 518-758-7557

Ms. Demerise Danielle Marshall, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2880 Us Highway 9 Ste 1, Valatie, NY 12184 Phone: 518-758-6070

Alain Nicolasora De Vera Physical Therapist Medicare: Medicare Enrolled Practice Location: 3230 Church St, Valatie, NY 12184 Phone: 518-758-6222

Stefanie L Ryan, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2827 Us Highway 9, Ocean State Job Lots Plaza, Valatie, NY 12184 Phone: 518-758-7616

Mr. Joseph Pelizza Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2827 Route 9, Grand Union Plaza, Valatie, NY 12184 Phone: 518-758-7616

News Archive

Study adds more evidence to the link between hearing loss and cognitive decline

Hearing loss affects tens of millions of Americans and its global prevalence is expected to grow as the world's population ages. A new study led by investigators at Brigham and Women's Hospital adds to a growing body of evidence that hearing loss is associated with higher risk of cognitive decline.

Researchers discover that humans are natural-born multi-taskers

Imagine you're a hockey goalie, and two opposing players are breaking in alone on you, passing the puck back and forth. You're aware of the linesman skating in on your left, but pay him no mind. Your focus is on the puck and the two approaching players. As the action unfolds, how is your brain processing this intense moment of "multi-tasking"? Are you splitting your focus of attention into multiple "spotlights?" Are you using one "spotlight" and switching between objects very quickly? Or are you "zooming out" the spotlight and taking it all in at once?

Researchers find new technique for long-term treatment of DVT

Deep Venous Thrombosis (DVT) is a serious condition that involves the formation of a blood clot inside of a deep vein usually in the legs. A patient with DVT is typically treated with anticoagulants (blood thinners) however researchers have found that image-guided interventional radiology procedures may play a more central role in the long-term treatment of DVT, according to a study published in the October issue of the American Journal of Roentgenology (AJR).

Synaptic levels of protein clathrin are determinant factor for plasticity of neurons

Researchers of the group of cellular and molecular neurobiology of the Bellvitge Biomedical Research Institute (IDIBELL) and the University of Barcelona, led by researcher Artur Llobet, have shown that synaptic levels of the protein clathrin are a determinant factor for synaptic plasticity of neurons.

Emergent BioSolutions completes sales, deliveries of BioThrax to allied international governments

Emergent BioSolutions Inc. announced today that it has completed separate international sales and deliveries of BioThrax® (Anthrax Vaccine Adsorbed) to governments of several allied nations. The company's international sales efforts have resulted in these sales of an undisclosed number of BioThrax doses for aggregate revenue of approximately $2.3 million in the second quarter.

Read more Medical News

› Verified 5 days ago